申请人:CENTRAX INTERNATIONAL INC
公开号:WO2014018807A1
公开(公告)日:2014-01-30
The present disclosure relates to novel compounds and pharmaceutical compositions thereof which are useful as inhibitors of proteasomes. The compounds provided herein are capable of inhibiting all three of CT-L, T-L, and PGPH activities of proteasomes, and are useful in treating various conditions or diseases associated with proteasomes.
本公开涉及新型化合物及其药物组合物,这些化合物可用作蛋白酶体的抑制剂。本文提供的化合物能够抑制蛋白酶体的CT-L、T-L和PGPH三种活性,并可用于治疗与蛋白酶体相关的各种疾病或症状。